Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Costochondritis Companies

ID: MRFR/Pharma/5038-HCR
90 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Costochondritis companies focus on innovative solutions for this inflammatory chest condition. Through research, development, and distribution, these organizations provide advanced treatments, addressing the discomfort associated with costochondritis and improving the overall well-being of affected individuals.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Costochondritis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)11.64%
2024 Market Size$ 1.55 Billion
2025 Market Size$ 1.73 Billion
2035 Market Size$ 5.21 Billion
Key Players
Pfizer Inc
Johnson & Johnson
Bristol-Myers Squibb Company
AbbVie Inc
Amgen Inc
Novartis AG
Opportunities
  • Rising Healthcare Expenditure
  • Advancements in Diagnostic Techniques
  • Increasing Incidence of Costochondritis

Top Industry Leaders in the Costochondritis Market

Costochondritis Market
 

Latest Costochondritis Companies Updates:

Johnson & Johnson's Ethicon unit launched the Enseal X1 Straight Jaw Tissue Sealer in April 2022. While not directly applicable to Costochondritis, this advanced device highlights J&J's continued investment in minimally invasive surgical tools, which could potentially be used in future surgical treatments for severe Costochondritis cases.

Stryker received FDA approval for BoTOX® for Glabellar Lines in August 2023. Again, not directly related to Costochondritis, this approval showcases the expanding applications of BoTOX® for pain management, potentially opening doors for future research on its use for Costochondritis-related pain.

List of Costochondritis companies in the market:

  • KemPharm
  • GlaxoSmithKline plc
  • Biovail Corporation
  • Aurobindo Pharma
  • Pfizer Inc
  • Recro Pharma Inc
  • LUPIN
  • Bausch Health Companies Inc
  • Avenue Therapeutics